Skip to main content

Whole Blood Transcriptome and Other Biomarkers in Nasopharyngeal Cancer

  • Reference work entry
Biomarkers in Cancer

Abstract

Nasopharyngeal carcinoma is often diagnosed only after the disease has reached late stages and the prognosis is poor. However, when detected early, the disease is highly survivable. This review surveys molecular biomarker studies that aim to identify early, presymptomatic disease, to predict response to treatment, to indicate prognosis, to identify tumor stage, and to monitor disease progression. Blood transcriptomic studies represent a new frontier in the molecular diagnostics of nasopharyngeal carcinoma.

Chun Ren Lim and Michelle Lee contributed equally to this manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

AUC:

Area Under the Curve

BCR:

B-cell Receptor

CR:

Complete Response to Treatment

CT:

Computed Tomography

DNA:

Deoxyribonucleic Acid

EBV:

Epstein-Barr Virus

EGFR1:

Epidermal Growth Factor Receptor 1

ELISA:

Enzyme-Linked Immunosorbent Assay

GWAS:

Genome-Wide Association Study

HLA:

Human Leukocyte Antigen

IgA:

Immunoglobulin A

IgG:

Immunoglobulin G

MHC:

Major Histocompatibility Complex

miRNA:

MicroRNA

MRI:

Magnetic Resonance Imaging

mRNA:

Messenger RNA

NPC:

Nasopharyngeal Carcinoma

PCR:

Polymerase Chain Reaction

PR:

Partial Response to Treatment

RNA:

Ribonucleic Acid

ROC:

Receiver Operating Characteristic Curve

SELDI-TOF-MS:

Surface-Enhanced Laser Desorption and Ionization-Time-of-Flight Mass Spectrometry

SNP:

Single Nucleotide Polymorphism

TNF:

Tumor Necrosis Factor

TNFR:

Tumor Necrosis Factor Receptor

TSG:

Tumor Suppressor Gene

VCA:

Viral Capsid Antigen

References

  • Agathanggelou A, Honorio S, Macartney DP, Martinex A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast, and ovarian tumours. Oncogene. 2001;20:1509–18.

    Article  CAS  PubMed  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Chemoradiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998;16:1310–7.

    CAS  PubMed  Google Scholar 

  • Ambinder RF, Robertson KD, Tao Q. DNA methylation and the Epstein-Barr virus. Semin Cancer Biol. 1999;9:369–75.

    Article  CAS  PubMed  Google Scholar 

  • Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.

    Article  CAS  PubMed  Google Scholar 

  • Aune TM, Maas K, Moore JH, Olsen NJ. Gene expression profiles in human autoimmune disease. Curr Pharm Des. 2003;9:1905–17.

    Article  CAS  PubMed  Google Scholar 

  • Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK, et al. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One. 2011;6:e17014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, Feng QS, Low HQ, Zhang H, He F, Tai ES, Kang T, Liu ET, Liu J, Zeng YX. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010;42:599–603.

    Article  CAS  PubMed  Google Scholar 

  • Bendaraf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, Syrjanen K, Collan Y, Pyrohonen S. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest. 2010;28:38–43.

    Article  Google Scholar 

  • Burakoff R, Hande S, Ma J, Banks PA, Friedman S, Makrauer F, Liew CC. Differential regulation of peripheral leukocyte genes in patients with active Crohn’s disease and Crohn’s disease in remission. J Clin Gastroenterol. 2010;44:120–6.

    Article  PubMed  Google Scholar 

  • Burakoff R, Chao S, Perencevich M, Ying J, Friedman S, Makrauer F, Odze R, Khurana H, Liew CC. Blood-based biomarkers can differentiate ulcerative colitis from Crohn’s disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011;17:1719–25.

    Article  PubMed  Google Scholar 

  • Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet. 1994;9:27–32.

    Article  Google Scholar 

  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.

    Article  CAS  PubMed  Google Scholar 

  • Caponigro F, Longo F, Ionna F, Perri F. Treatment approaches to nasopharyngeal carcinoma: a review. Anticancer Drugs. 2010;21:471–7.

    Article  CAS  PubMed  Google Scholar 

  • Chan KCA, Hung ECW, Woo JKS, Chan PKS, Leung SF, Lai FPT, Cheng ASM, Yeung SW, Chan YW, Tsui TKC, Kwok JSS, King AD, Chan ATC, van Hasselt AC, Lo YMD. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer. 2013;119:1834–44.

    Google Scholar 

  • Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765–77.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Shpall RL, Meyerdierks A, Hagemeier M, Böttger EC, Naumovski L. Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35. J Biol Chem. 2000;275:36278–84.

    Article  CAS  PubMed  Google Scholar 

  • Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ. microRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer. 2009;100:1002–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res. 2004;10:43–52.

    Article  CAS  PubMed  Google Scholar 

  • Dammann R, Yang G, Pfeifer G. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res. 2001;61:3105–9.

    CAS  PubMed  Google Scholar 

  • Doustjalali SR, Yusof R, Govindasamy GK, Bustam AZ, Pillay B, Hashim OH. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest. 2006;53:20–8.

    Article  PubMed  Google Scholar 

  • Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood. 2004;104:923–32.

    Article  CAS  PubMed  Google Scholar 

  • Ezhkova E, Lien WH, Stokes N, Pasolli HA, Silva JM, Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 2011;25:485–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood. 1999;93:3044–52.

    CAS  PubMed  Google Scholar 

  • Fendri A, Kontos CK, Khabir A, Mokdad-Gargouri R, Ardavanis A, Scorilas A. Quantitative analysis of BLC2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor. Tumor Biol. 2010;31:391–9.

    Article  CAS  Google Scholar 

  • Fendri A, Kontos CK, Khabir A, Mokdad-Gargouri R, Scorilas A. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Mol Med. 2011;17:163–71.

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D. Cancer incidence in five continents, volumes I to IX: IARC cancer base no 9, Lyon: International Agency for Research on Cancer; 2010. http://ci5.iarc.fr. Accessed 27 May 2013.

  • Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N, Han M, Liew CC, Tsuang MT. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A. 2005;102:15533–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glatt SJ, Stone WS, Nossova N, Liew CC, Seidman LJ, Tsuang MT. Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:869–87.

    Article  PubMed  Google Scholar 

  • Gu AD, Lu LX, Xie YB, Chen LZ, Feng QS, Kang T, Jia WH, Zeng YX. Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology. J Transl Med. 2009;7:73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case–control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev. 1995;4:607–10.

    CAS  PubMed  Google Scholar 

  • Hildesheim A, Anderson LM, Chen CJ, Cheng YK, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 1997;89:1207–12.

    Article  CAS  PubMed  Google Scholar 

  • Hildesheim A, Apple RJ, Chen C, Wang SS, Cheng YK, Klitz W, Mack SJ, Chen IH, Hsu MM, Yang CS, Brinton LA, Levine PH, Erlich HA. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 2002;94:1780–9.

    Article  CAS  PubMed  Google Scholar 

  • Iorio MV, Ferracin M, Liu CG, Veronesse A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. microRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065–70.

    Article  CAS  PubMed  Google Scholar 

  • Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Feldhaus W, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 1994;8:22–6.

    Article  CAS  Google Scholar 

  • Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greene MI, Reed JC. Differential effects of bcl-2 on t and b cells in transgenic mice. Proc Natl Acad Sci U S A. 1992;89:11376–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010;6:e1000940.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kong SW, Collins CD, Shimizu-Motohashi Y, Holm I, Campbell MG, Lee IH, Brewster SJ, Hanson E, Harris HK, Lowe KR, Saada A, Mora A, Madison K, Hundley R, Egan J, McCarthy J, Eran A, Galdzicki M, Rappaport L, Kunkel LM, Kohane IS. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS One. 2012;7:e49475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kurosaki T, Shinohara H, Baba Y. B cell signaling and fate decision. Annu Rev Immunol. 2010;28:21–55.

    Article  CAS  PubMed  Google Scholar 

  • Kwong J, Lo KW, To KF, Teo PML, Johnson PJ, Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res. 2002;8:131–7.

    CAS  PubMed  Google Scholar 

  • Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;4:253–66.

    Article  Google Scholar 

  • Lampe JW, Stepaniants SB, Mao M, Radich JP, Dai H, Linsley PS, Friend SH, Potter JD. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev. 2004;13:445–53.

    CAS  PubMed  Google Scholar 

  • Le QT, Jones CD, Yau TK, Shirazi HA, Wong PH, Thomas EN, Patterson BK, Lee AWM, Zehnder JL. A comparison study of different PCR assays in measuring circulating plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res. 2005;11:5700–7.

    Article  CAS  PubMed  Google Scholar 

  • Le QT, Zhang Q, Cao H, Cheng AJ, Pinsky BA, Hong RL, Chang JT, Wang CW, Tsao KC, Lo YMD, Lee N, Ang KK, Chan ATC, Chan KCA. An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma. Clin Cancer Res. 2013;19:2208–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li F, Guan Y, Chen Z. Proteomics in nasopharyngeal carcinoma. Cell Mol Life Sci. 2008;65:1007–12.

    Article  CAS  PubMed  Google Scholar 

  • Liew CC. Method for the detection of gene transcripts in blood and uses thereof. U.S. patent application no 2002000268730; 1999.

    Google Scholar 

  • Liong ML, Lim CR, Yang H, Chao S, Bong CW, Leong WS, Das PK, Loh CS, Lau BE, Yu CG, Ooi EJJ, Nam RK, Allen PD, Steele GS, Wassman K, Richie JP, Liew CC. Blood-based biomarkers of aggressive prostate cancer. PLoS One. 2012;7:e45802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu Z, Li L, Yang Z, Luo W, Yang H, Yao K, Wu B, Fang W. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer. 2010;10:270.

    Article  PubMed  PubMed Central  Google Scholar 

  • Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QN, Jiang N, Chen L, Cho WCS, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012;13:633–41.

    Article  CAS  PubMed  Google Scholar 

  • Lo YMD, Chan LYS, Lo KW, Leung SF, Zhang J, Chan ATC, Lee JCK, Hjelm M, Johnson PJ, Huang DP. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Canc Res. 1999;59:1188–91.

    CAS  Google Scholar 

  • Lu TY, Kao CF, Lin CT, Huang DY, Chiu CY, Huang YS, Wu HC. DNA methylation and histone modification regulate silencing of OPG during tumor progression. J Cell Biochem. 2009;108:315–25.

    Article  CAS  PubMed  Google Scholar 

  • Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM. Cutting edge: molecular portrait of human autoimmune disease. J Immunol. 2002;169:5–9.

    Article  CAS  PubMed  Google Scholar 

  • Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, Aoki S, Minami M, Uozaki H, Fukayama M, Ohtomo K. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol. 2009;27:4–19.

    Article  PubMed  Google Scholar 

  • Marshall KW, Mohr S, Khettabi FE, Nossova N, Chao S, Bao W, Ma J, Li XJ, Liew CC. A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer. 2010;126:1177–86.

    CAS  PubMed  Google Scholar 

  • Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25:2537–45.

    Article  CAS  PubMed  Google Scholar 

  • National Cancer Registry, Ministry of Health Malaysia. Malaysia cancer statistics: data and figures peninsular Malaysia. Kuala Lumpur: National Cancer Registry, Ministry of Health Malaysia; 2006. http://www.makna.org.my/PDF/MalaysiaCancerStatistics.pdf. Accessed 1 Aug 2013. ISBN 978-983-3433-51-3.

  • Ng CC, Yew PY, Puah SM, Krishnan G, Yap LF, Teo SH, Lim PVH, Govindraju S, Ratnevelu K, Sam CK, Takahashi A, Kubo M, Kamatani N, Nakamura Y, Mushiroda T. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet. 2009;54:392–7.

    Article  CAS  PubMed  Google Scholar 

  • Okazaki M, Ishibashi Y, Asoh S, Ohta S. Overexpressed mitochondrial hinge protein, a cytochrome c-binding protein, accelerates apoptosis by enhancing the release of cytochrome c from mitochondria. Biochem Biophys Res Commun. 1998;243:131–6.

    Article  CAS  PubMed  Google Scholar 

  • Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC. Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res. 2006;12:3374–80.

    Article  CAS  PubMed  Google Scholar 

  • Provatopoulou X, Gounaris A, Kalogera E, Zagouri F, Flessas I, Goussestis E, Nonni A, Papassotoriou I, Zografos G. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer. 2009;9:390.

    Article  PubMed  PubMed Central  Google Scholar 

  • Quest Diagnostics. About ColoVantage®. 2013. Available from: http://www.questdiagnostics.com/home/physicians/testing-services/by-test-name/colovantage/about. Accessed 1 Aug 2013.

  • Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell. 2003;3:17–22.

    Article  CAS  PubMed  Google Scholar 

  • Robertson K. DNA methylation and human disease. Nat Rev Genet. 2005;6:597–610.

    Article  CAS  PubMed  Google Scholar 

  • Rosetta Genomics: Testing Services. Philadelphia; 2013. Available from: http://www.rosettagenomics.com/testing-services. Accessed 1 Aug 2013.

  • Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. microRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008;105:5874–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stevens SJ, Verjukilen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer. 2006;119:608–14.

    Google Scholar 

  • Thalasila A, Poplin E, Shih J, Dvorzhinski D, Capanna T, Doyle-Lindrud S, Beers S, Goodin S, Rubin E, DiPaola RS. A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies. Cancer Chemother Pharmacol. 2003;52:119–24.

    Article  CAS  PubMed  Google Scholar 

  • Thomodaki H, Scorilas A. Bcl2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci. 2006;43:1–67.

    Article  Google Scholar 

  • Tiwawech D, Srivatanakul P, Karalak A, Ishida T. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett. 2006;241:135–41.

    Article  CAS  PubMed  Google Scholar 

  • Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Head Neck. 2004;26:598–602.

    Article  PubMed  Google Scholar 

  • Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, See LC, Hsueh C, Yang ML, Hao SP, Li HY, Wang MH, Liao LP, Chen LC, Lin SR, Jorgensen TJ, Chang YS, Shugart YY. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet. 2009;85:194–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, Liew CC. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005;133B:1–5.

    Article  PubMed  Google Scholar 

  • Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, Slonim DK, Trepicchio WL, Burczynski ME. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res. 2003;63:6069–75.

    CAS  PubMed  Google Scholar 

  • Van Buren P, Ma J, Chao S, Mueller E, Schneider DJ, Liew CC. Blood gene expression signatures associate with heart failure outcomes. Physiol Genomics. 2011;43:392–7.

    Article  Google Scholar 

  • Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440–2.

    Article  CAS  PubMed  Google Scholar 

  • Vincenz C, Dixit VM. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem. 1996;271:20029–34.

    Article  CAS  PubMed  Google Scholar 

  • Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant radiotherapy in patients with American Joint Committee on Cancer/International Union against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23:6730–8.

    Article  CAS  PubMed  Google Scholar 

  • Wei WI, Sham JST. Nasopharyngeal carcinoma. Lancet. 2005;365:2041–54.

    Article  PubMed  Google Scholar 

  • Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang ZH, Lv ML, Jia J, Zhang L. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer. 2008;112:544–51.

    Article  CAS  PubMed  Google Scholar 

  • White HE, Durston VJ, Harvery JF, Cross NCP. Quantitative analysis of SRNPN gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. Clin Chem. 2006;52:1005–13.

    Article  CAS  PubMed  Google Scholar 

  • Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, Tsao CH, Chang YS, Yu JS. Cancer cell secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics. 2005;5:3173–82.

    Article  CAS  PubMed  Google Scholar 

  • Zaatar AM, Lim CR, Bong CW, Lee MML, Ooi JJ, Suria D, Raman R, Chao S, Yang H, Neoh SB, Liew CC. Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2012;31:76.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhao ZS, Wang YY, Ye ZY, Tao HQ. Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res. 2008;15:589–96.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Choong Chin Liew .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this entry

Cite this entry

Lim, C.R., Lee, M.M.L., Chao, S., Zaatar, A., Liew, C.C. (2015). Whole Blood Transcriptome and Other Biomarkers in Nasopharyngeal Cancer. In: Preedy, V., Patel, V. (eds) Biomarkers in Cancer. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7681-4_3

Download citation

Publish with us

Policies and ethics